Acquired von Willebrand syndrome: An important bleeding complication to be considered in patients with lymphoproliferative and myeloproliferative disorders

Hematology Journal

Volumn 2, Issue 6, 2001, Pages 358-362

  Federici, A B ^a   Rand, J H ^a   Mannucci, P M ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Acquired von Willebrand syndrome; Desmopressin; Factor VIII von Willebrand factor concentrates; Immunoglobulins; Lymphoproliferative and myeloproliferative disorders

Indexed keywords

BLOOD CLOTTING FACTOR 8; CORTICOSTEROID; DESMOPRESSIN; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; VON WILLEBRAND FACTOR;

ARTICLE; BLEEDING; BLOOD TRANSFUSION; CONTROLLED STUDY; COST; DRUG HALF LIFE; FEMALE; HUMAN; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; MYELOPROLIFERATIVE DISORDER; PLASMAPHERESIS; VON WILLEBRAND DISEASE;

FEMALE; HEMORRHAGE; HEMOSTATICS; HUMANS; LYMPHOPROLIFERATIVE DISORDERS; MALE; MYELOPROLIFERATIVE DISORDERS; VON WILLEBRAND DISEASE;

EID: 0035670365     PISSN: 14664860     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.thj.6200137     Document Type: Article

References (20)

1. Diagnosis of von Willebrand disease
2. The 20-year (1978-1998) natural history of von Willebrand disease in Italy: A multicentre retrospective analysis on diagnosis and therapy in 1234 patients
3. Acquired von Willebrand's syndrome in systemic lupus erythematosus
4. Acquired von Willebrand's disease: A concise review
5. Acquired von Willebrand disease: Concise review of occurrence, diagnosis, pathogenesis and treatment
6. Acquired von Willebrand Syndrome: Data from an international registry
7. Acquired von Willebrand Syndrome: From pathophysiology to management
8. Quantitative analysis of von Willebrand factor and its propeptide in plasma in acquired von Willebrand syndrome
9. Clinical significance of inhibitors in acquired von Willebrand syndrome
10. Studies of the pathophysiology of acquired von Willebrand Disease in seven patients with lymphoproliferative disorders or benign monoclonal gammopathies
11. Treatment of acquired von Willebrand syndrome in patients with monoclonal gammopathy of uncertain significance: Comparison of three different therapeutic approaches
12. Therapeutic approaches to acquired von Willebrand syndrome
13. Four cases of acquired von Willebrand's syndrome
14. Acquired von Willebrand's disease caused by a chronic granulocytic leukemia
15. Acquired von Willebrand's disease in the myeloproliferative syndrome
16. Subunit composition of plasma von Willebrand factor in patients with the myeloproliferative syndrome
17. Acquired von Willebrand Disease in patients with Polycythemia Rubra Vera
18. Essential thrombocythemia with acquired von Willebrand's Disease
19. Multimeric composition of plasma von Willebrand Factor in chronic myelocytic leukaemia
20. Acquired von Willebrand disease as a cause of recurrent mucocutaneous bleeding in primary thrombocythemia: Relationship with platelet count